Goldman Sachs, VeriSign And 2 Other Stocks Insiders Are Selling
Portfolio Pulse from Lisa Levin
Insiders at VeriSign, Tenet Healthcare, Goldman Sachs, and Dycom Industries have recently sold shares. VeriSign's CEO sold shares after reporting lower-than-expected revenue. Tenet Healthcare's director sold shares following an agreement to sell hospitals for $2.4 billion. Goldman Sachs' CAO sold shares amidst news of the Japan President stepping down. Dycom Industries' CAO sold shares after reporting strong financial results. Insider sales can indicate various sentiments about the company's prospects and stock valuation.
November 27, 2023 | 1:27 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Tenet Healthcare Director sold 6,000 shares at $66.65 each after the company announced a $2.4 billion hospital sale, which could be seen as profit-taking from the news.
The director's sale might be perceived as a routine profit-taking following a significant asset sale, which may not necessarily impact the stock price in the short term.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Dycom Industries CAO sold 2,268 shares at $102.10 each after the company reported better-than-expected financial results, which could be interpreted as a surprising move given the positive news.
The CAO's decision to sell shares after positive financial results could be seen as counterintuitive, potentially raising questions about the stock's future performance.
CONFIDENCE 65
IMPORTANCE 55
RELEVANCE 65
NEGATIVE IMPACT
Goldman Sachs CAO sold 1,376 shares at $335.15 each amid news of the Japan President's departure, possibly reflecting internal changes affecting sentiment.
The CAO's sale coinciding with the Japan President's departure could suggest uncertainty or a negative outlook internally, which may affect the stock price negatively.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
VeriSign CEO sold 15,000 shares at $213.55 each after reporting lower-than-expected Q3 revenue, indicating potential concerns about the company's future performance.
The CEO's sale of shares following a worse-than-expected revenue report could be interpreted as a lack of confidence in the near-term prospects of the company, potentially influencing the stock negatively.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80